Logo image of CGX.CA

CINEPLEX INC (CGX.CA) Stock Fundamental Analysis

Canada - TSX:CGX - CA1724541000 - Common Stock

12.01 CAD
+0.15 (+1.26%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

4

Overall CGX gets a fundamental rating of 4 out of 10. We evaluated CGX against 13 industry peers in the Entertainment industry. CGX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CGX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CGX has reported negative net income.
CGX had a positive operating cash flow in the past year.
In multiple years CGX reported negative net income over the last 5 years.
CGX had a positive operating cash flow in 4 of the past 5 years.
CGX.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CGX's Return On Assets of -2.72% is fine compared to the rest of the industry. CGX outperforms 76.92% of its industry peers.
CGX has a better Return On Invested Capital (4.56%) than 92.31% of its industry peers.
CGX had an Average Return On Invested Capital over the past 3 years of 3.36%. This is in line with the industry average of 4.45%.
The 3 year average ROIC (3.36%) for CGX is below the current ROIC(4.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.72%
ROE N/A
ROIC 4.56%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
CGX.CA Yearly ROA, ROE, ROICCGX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

CGX has a Operating Margin of 7.92%. This is amongst the best in the industry. CGX outperforms 100.00% of its industry peers.
CGX's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 66.63%, CGX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CGX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.92%
PM (TTM) N/A
GM 66.63%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
CGX.CA Yearly Profit, Operating, Gross MarginsCGX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CGX is destroying value.
The number of shares outstanding for CGX has been reduced compared to 1 year ago.
Compared to 5 years ago, CGX has about the same amount of shares outstanding.
Compared to 1 year ago, CGX has an improved debt to assets ratio.
CGX.CA Yearly Shares OutstandingCGX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGX.CA Yearly Total Debt VS Total AssetsCGX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.14, we must say that CGX is in the distress zone and has some risk of bankruptcy.
CGX's Altman-Z score of 0.14 is fine compared to the rest of the industry. CGX outperforms 69.23% of its industry peers.
The Debt to FCF ratio of CGX is 22.36, which is on the high side as it means it would take CGX, 22.36 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CGX (22.36) is better than 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 22.36
Altman-Z 0.14
ROIC/WACC0.61
WACC7.43%
CGX.CA Yearly LT Debt VS Equity VS FCFCGX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CGX has a Current Ratio of 0.31. This is a bad value and indicates that CGX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.31, CGX is doing worse than 61.54% of the companies in the same industry.
CGX has a Quick Ratio of 0.31. This is a bad value and indicates that CGX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.28, CGX is doing worse than 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.28
CGX.CA Yearly Current Assets VS Current LiabilitesCGX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for CGX have decreased strongly by -375.00% in the last year.
CGX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.67%.
The Revenue has been decreasing by -4.39% on average over the past years.
EPS 1Y (TTM)-375%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.91%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%30.46%

3.2 Future

The Earnings Per Share is expected to grow by 57.64% on average over the next years. This is a very strong growth
CGX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.22% yearly.
EPS Next Y122.6%
EPS Next 2Y82.35%
EPS Next 3Y57.64%
EPS Next 5YN/A
Revenue Next Year5.15%
Revenue Next 2Y5.97%
Revenue Next 3Y5.22%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGX.CA Yearly Revenue VS EstimatesCGX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CGX.CA Yearly EPS VS EstimatesCGX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CGX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 15.36, the valuation of CGX can be described as correct.
Based on the Price/Forward Earnings ratio, CGX is valued cheaper than 84.62% of the companies in the same industry.
CGX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.86.
Industry RankSector Rank
PE N/A
Fwd PE 15.36
CGX.CA Price Earnings VS Forward Price EarningsCGX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CGX is valued a bit cheaper than 76.92% of the companies in the same industry.
76.92% of the companies in the same industry are more expensive than CGX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.12
EV/EBITDA 9.11
CGX.CA Per share dataCGX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CGX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CGX's earnings are expected to grow with 57.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.35%
EPS Next 3Y57.64%

0

5. Dividend

5.1 Amount

No dividends for CGX!.
Industry RankSector Rank
Dividend Yield N/A

CINEPLEX INC

TSX:CGX (9/19/2025, 7:00:00 PM)

12.01

+0.15 (+1.26%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners29.68%
Inst Owner ChangeN/A
Ins Owners1.98%
Ins Owner ChangeN/A
Market Cap761.91M
Analysts76
Price Target13.11 (9.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.04%
Min EPS beat(2)-153.04%
Max EPS beat(2)-29.05%
EPS beat(4)0
Avg EPS beat(4)-170.56%
Min EPS beat(4)-413.09%
Max EPS beat(4)-29.05%
EPS beat(8)2
Avg EPS beat(8)-677.12%
EPS beat(12)5
Avg EPS beat(12)-414.62%
EPS beat(16)7
Avg EPS beat(16)-307.21%
Revenue beat(2)1
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)0.2%
Revenue beat(4)2
Avg Revenue beat(4)-2.13%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)-2.34%
Revenue beat(12)8
Avg Revenue beat(12)-0.72%
Revenue beat(16)11
Avg Revenue beat(16)-0.12%
PT rev (1m)-3.02%
PT rev (3m)-3.02%
EPS NQ rev (1m)11.06%
EPS NQ rev (3m)-12.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-71.3%
Revenue NQ rev (1m)-3.94%
Revenue NQ rev (3m)-7.59%
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-1.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.36
P/S 0.55
P/FCF 9.12
P/OCF 4.91
P/B N/A
P/tB N/A
EV/EBITDA 9.11
EPS(TTM)-0.95
EYN/A
EPS(NY)0.78
Fwd EY6.51%
FCF(TTM)1.32
FCFY10.97%
OCF(TTM)2.45
OCFY20.38%
SpS21.82
BVpS-1.19
TBVpS-12.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.72%
ROE N/A
ROCE 6.33%
ROIC 4.56%
ROICexc 4.67%
ROICexgc 7.98%
OM 7.92%
PM (TTM) N/A
GM 66.63%
FCFM 6.04%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
ROICexc(3y)3.46%
ROICexc(5y)N/A
ROICexgc(3y)5.89%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.1%
ROICexc growth 3YN/A
ROICexc growth 5Y0.06%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
F-Score3
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 22.36
Debt/EBITDA 6.27
Cap/Depr 41.13%
Cap/Sales 5.18%
Interest Coverage 0.84
Cash Conversion 54.67%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.28
Altman-Z 0.14
F-Score3
WACC7.43%
ROIC/WACC0.61
Cap/Depr(3y)39.73%
Cap/Depr(5y)33.4%
Cap/Sales(3y)5.83%
Cap/Sales(5y)8.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-375%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.91%
EPS Next Y122.6%
EPS Next 2Y82.35%
EPS Next 3Y57.64%
EPS Next 5YN/A
Revenue 1Y (TTM)15.67%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%30.46%
Revenue Next Year5.15%
Revenue Next 2Y5.97%
Revenue Next 3Y5.22%
Revenue Next 5YN/A
EBIT growth 1Y41.53%
EBIT growth 3YN/A
EBIT growth 5Y-7.81%
EBIT Next Year216.27%
EBIT Next 3Y55.93%
EBIT Next 5Y28.47%
FCF growth 1Y10.03%
FCF growth 3Y41.4%
FCF growth 5Y-13.75%
OCF growth 1Y-4.04%
OCF growth 3Y38.48%
OCF growth 5Y-12.79%